SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-027677
Filing Date
2009-07-30
Accepted
2009-07-30 16:14:47
Documents
8
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a53234e10vq.htm 10-Q 424954
2 EX-5.1 a53234exv5w1.htm EX-5.1 6343
3 EX-10.1 a53234exv10w1.htm EX-10.1 56168
4 EX-10.2 a53234exv10w2.htm EX-10.2 149655
5 EX-31.1 a53234exv31w1.htm EX-31.1 6733
6 EX-31.2 a53234exv31w2.htm EX-31.2 7017
7 EX-32.1 a53234exv32w1.htm EX-32.1 3560
8 GRAPHIC a53234a5323401.gif GRAPHIC 2397
  Complete submission text file 0000950123-09-027677.txt   659511
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 09973938
SIC: 2834 Pharmaceutical Preparations